A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)

What is the purpose of this trial?

The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism in children with all levels of fecal chymotrypsin.


Participation Guidelines

Ages: 3 - 8 years

Gender: Both


Curemark, LLC

Dates: 11/01/2015 - 09/30/2017

Last Updated: 10/23/2016

Study HIC#: 1505015948

Get Involved

For more information about this study, contact:
Erin S MacDonnell
203-737-3439
erin.macdonnell@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Roger J. Jou

Principal Investigator

Sub-Investigators